Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
about
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cellsStructure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorThe Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsHuman cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor.The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteinsMultiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cellsDiversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.A single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation.Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules.Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.KIR and HLA under pressure: evidences of coevolution across worldwide populations.Current strategies for protein production and purification enabling membrane protein structural biology.A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.Killer cell inhibitory receptors: diversity, specificity, and function.Arousal and inhibition of human NK cells.Allelic Polymorphism Determines Surface Expression or Intracellular Retention of the Human NK Cell Receptor KIR2DL5A (CD158f).CD2 and the nature of protein interactions mediating cell-cell recognition.Characterization of an HLA-C-restricted CTL response in chronic HIV infection.Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.
P2860
Q24294775-D7823D2C-9979-464B-9B50-56A7E62C4CEEQ24671977-FE0C8DD7-85ED-49A0-B4FE-1F5D71A140F4Q26742135-86B85A09-28A7-4668-8B48-57FA00542E07Q27617783-8EFB86AA-6246-4AC8-8A21-D44547D956E5Q28776435-4421553D-965F-4F2E-AA4B-ADEBB5D0A842Q33851857-19C59D95-9A14-4398-8713-C6AA66251E4EQ33902254-62184611-990D-4C95-AD28-527A17A64EF4Q34100457-A6BACE1A-5588-4545-B5F7-9C89378E1A51Q34122073-80C218C3-EEB6-49DC-AB03-A43299A7279EQ34650773-EAC819F1-B36E-468B-8D59-159CE308EAF7Q34810583-10E90518-2975-4E83-B8CB-3A52C112BFB2Q35000087-2993B3DE-0220-49DC-9FC5-D89FF88134C5Q35030968-D798CB3A-BB7F-4D49-BAEA-8C4EFE2FA1ACQ36377146-785E87AB-C23F-4211-90ED-855B0B857816Q36685319-542DC866-9F4F-4658-A640-163BBC19432DQ36760435-BAD09513-07C3-433B-AB4E-82A6355EEE18Q36948245-1E927829-C1BB-49FE-9788-56C6B8085424Q38534398-F38050CB-EB4A-4AB9-9868-4266C91CB737Q38787163-0CC02CDB-9400-49FE-8E85-C66DCEF149ECQ39289753-3347A652-9CD0-4E7C-BC38-0D1E07A835CBQ39639898-D9B68FAE-CE2E-4CCA-807A-D1817F1108C3Q41373720-4FBC39FF-957D-427B-84A8-823A7858D9C1Q41373731-3510E4C4-871E-43DB-BA84-0AB4237DB3D1Q43017264-9AD847B7-120D-4880-9AF3-19ECF23CED93Q47699998-89A313C2-5225-4124-BB01-81B2687E40BAQ51887528-0BB326D9-AA70-4F7F-ABF2-1A6BC0935DD7Q55405564-6A967611-96F7-4EE6-8EBB-F6646B81BED5
P2860
Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct binding of a soluble na ...... compatibility complex molecule
@en
Direct binding of a soluble na ...... ompatibility complex molecule.
@nl
type
label
Direct binding of a soluble na ...... compatibility complex molecule
@en
Direct binding of a soluble na ...... ompatibility complex molecule.
@nl
prefLabel
Direct binding of a soluble na ...... compatibility complex molecule
@en
Direct binding of a soluble na ...... ompatibility complex molecule.
@nl
P2093
P2860
P356
P1476
Direct binding of a soluble na ...... compatibility complex molecule
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.14.7178
P407
P577
1996-07-01T00:00:00Z